Long-Term High Flow Nasal Cannula Therapy in Primary and Secondary Bronchiectasis.

Francesca Simioli Giuseppe FiorentinoRosa CauteruccioAntonietta CoppolaPasquale ImitazioneAntonella MarottaValentina Di SpiritoAnna Annunziata

Published in: Healthcare (Basel, Switzerland) (2023)

HFNC is a well-tolerated add-on therapy for adult bronchiectasis. Dyspnea improved after 2 months and further after 2 years. The exacerbation rate decreased during the 2 years follow-up. No significant difference was observed in lung function.

Keyphrases

lung function
cystic fibrosis
chronic obstructive pulmonary disease
air pollution
respiratory failure
positive airway pressure
young adults
bone marrow